Sequence information
Variant position: 104 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 371 The length of the canonical sequence.
Location on the sequence:
ADLAVALFQVLPQLAWKATD
R FRGPDALCRAVKYLQMVGMY
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human ADLAVALFQVLPQLAWKATDR FRGPDALCRAVKYLQMVGMY
ADLAVALFQVLPQLAWDATDR FRGPDALCRAVKYLQMVGMY
Mouse ADLAVALFQVLPQLAWDATDR FHGPDALCRAVKYLQMVGMY
Rat ADLAVALFQVLPQLAWDATDR FHGPDALCRAVKYLQMVGMY
Pig ADLAVALFQVLPQLAWDATYR FRGPDALCRAVKYLQMVGMY
Bovine ADLAVALFQVLPQLAWDATDR FRGPDALCRAVKYLQMVGMY
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 371
Vasopressin V2 receptor
Topological domain
99 – 113
Extracellular
Literature citations
The property of a novel V2 receptor mutant in a patient with nephrogenic diabetes insipidus.
Inaba S.; Hatakeyama H.; Taniguchi N.; Miyamori I.;
J. Clin. Endocrinol. Metab. 86:381-385(2001)
Cited for: VARIANT XNDI CYS-104;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.